CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 194 enrolled
Drug / intervention
Partition defocus myopia management spectacle lens +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05740930
NCT05740930N/ACompleted

Effectiveness and Safety of Partition Multi-point Defocused Myopia Management Spectacle Lens in Myopia Control Compared With Spectacle Lenses With Aspherical Lenslets: a Randomised Non-inferiority Trial

Zhongshan Ophthalmic Center, Sun Yat-sen University·interventional·Posted Feb 23, 2023·Updated Mar 12, 2026

In Brief

A clinical study evaluating Partition defocus myopia management spectacle lens and Spectacle lenses with aspherical lenslets for Myopia. Completed, enrolled 194 participants across 1 site.

Detailed Summary

Myopia is considered to be the most common type of refractive error, and the incidence of myopia has shown a trend of low age. Recent studies found that the new aspheric microlens spectacle lens can more effectively control the progress of diopter than the single-vision spectcale lens. A new technology of equivalent defocusing around the lens called the partition multi-point defocus optical technology is adopted in this study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 23, 2023
Enrollment StartMar 20, 2023
Primary CompletionMay 27, 2025
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 3.4 years ago

Interventions

Partition defocus myopia management spectacle lensother

Participants in the intervention group will receive the partition defocus myopia management spectacles lens and receive follow-up checks.

Spectacle lenses with aspherical lensletsother

Participants in the control group will receive the spectacle lenses with aspherical lenslets and receive follow-up checks.